Article

Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease.

INSERM ERM 0220, Hôpital Saint Louis, AP-HP, 1 Avenue Claude Vellefaux, 75475 Paris Cedex 10, France.
Blood (Impact Factor: 9.06). 07/2004; 103(12):4681-4. DOI: 10.1182/blood-2003-05-1548
Source: PubMed

ABSTRACT In an experimental model we demonstrated that endothelial cells of all organs are targets of the alloimmune reaction. Here, in 68 digestive biopsies, we found endothelial lesions by immunohistochemistry and ultrastructure in patients with severe acute graft-versus-host disease (GVHD). In contrast, no such endothelial cell alterations were found either in patients without GVHD or in nongrafted controls. In the biopsies with severe GVHD lesions, ultrastructure showed rupture of the capillary basal membrane and extravased red blood cells. These pericapillary hemorrhages were highly correlated with GVHD severity. In a separate cohort of 39 patients who underwent an allogeneic transplantation after a nonmyeloablative conditioning, 8 patients had intestinal biopsies. Three of these latter patients had both severe pathologic lesions of GVHD and similar endothelial lesions, thus, strengthening the concept that endothelial lesions are linked to GVHD severity and not to the intensity of the conditioning regimen. (Blood. 2004;103:4681-4684)

0 Bookmarks
 · 
66 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intestinal acute GVHD (I-aGVHD) is a life-threatening complication after allografting. Non-invasive bed-side procedures to evaluate extension and treatment response are still lacking. We hypothesized that, during I-aGVHD, contrast-enhanced ultrasound sonography (CEUS) could detect microcirculation changes (MVC) of the bowel wall (BW) and help to monitor treatment response. We prospectively employed CEUS in 83 consecutive patients. Of these, 14 patients with biopsy-proven intestinal GVHD (I-GVHD) were defined as the study group, whereas 16 patients with biopsy-proven stomach GVHD (U-GVHD) without intestinal symptoms, 6 normal volunteers and 4 patients with neutropenic enterocolitis were defined as the control group. All patients were evaluated with both standard ultrasonography (US) and CEUS at the onset of intestinal symptoms, during clinical follow-up and at flare of symptoms. Standard US revealed BW thickening of multiple intestinal segments, useful to determine the extension of GVHD. CEUS showed MVC, which correlated with GVHD activity, treatment response, and predicted flare of intestinal symptoms. US and CEUS findings were superimposable at diagnosis and in remission. CEUS was, however, more sensitive and specific to identify subclinical activity in patients with clinical relevant improvement. These findings were not observed in the control groups. CEUS is a non-invasive, easily reproducible bed-side tool useful to monitor I-aGVHD.Bone Marrow Transplantation advance online publication, 13 May 2013; doi:10.1038/bmt.2013.65.
    Bone marrow transplantation 05/2013; · 3.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: One reason for the lack of progress in the treatment of acute graft versus host disease (GVHD) is the lack of reliable biomarkers. GVHD of the gastrointestinal (GI) tract is closely associated with non-relapse mortality (NRM) following hematopoietic cell transplantation (HCT). Using an unbiased, large-scale, quantitative proteomic discovery approach, we identified candidate biomarkers that were increased in plasma from HCT patients with GI GVHD. We then validated the lead candidate, REG3α, by ELISA in samples from more than 1000 HCT patients from three transplant centers. Plasma REG3α concentrations were 3-fold higher in patients at GI GVHD onset than in all other patients. REG3α concentrations correlated most closely with lower GI GVHD at GVHD onset and predicted response to therapy at 4 weeks, 1-year NRM, and 1-year survival (P ≤ 0.001). Multivariate analysis showed that advanced clinical stage, severe histologic damage, and high REG3α concentrations at the diagnosis of GVHD independently predicted 1-year NRM, which progressively increased with higher numbers of onset risk factors present. We conclude that REG3α is a plasma biomarker of GI GVHD that can be combined with clinical stage and histologic grade to improve risk stratification of patients, perhaps providing a platform for advances in the treatment of high-risk GVHD.
    Best practice & research. Clinical haematology 12/2012; 25(4):473-8. · 3.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Steroid non-responsive acute graft-versus-host disease (aGvHD) following hematopoietic stem cell transplantation carries a poor prognosis. Various groups have reported beneficial effects of mesenchymal stromal cells (MSC) as salvage treatment. Response to treatment is typically evaluated using the diagnostic clinical criteria for aGvHD. In this study we report the usefulness of additional gastrointestinal biopsies paired with serum biomarkers. In a cohort of 22 pediatric patients, persistent or recurrent diarrhea was seen in 18 children treated with MSC for steroid refractory aGvHD. To exclude other causes of gastrointestinal pathology, patients were biopsied for histological analysis. In 8 out of 12 patients, residual tissue damage and villous atrophy, but no active aGvHD was seen. Serum biomarkers have been described as alternatives to monitor response to aGvHD treatment. The value of biomarkers for inflammation, tissue and endothelial cell damage was evaluated in our cohort. Although predictive for response to treatment and survival, we demonstrate that these markers lack the required specificity and sensitivity to predict response to MSC therapy. Objective end-points for clinical trials on the treatment of steroid refractory aGvHD have yet to be defined. We therefore recommend that biopsies and biomarkers are included to discriminate between ongoing aGvHD and post inflammatory malabsorption.
    Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 08/2013; · 3.15 Impact Factor

Full-text (2 Sources)

View
28 Downloads
Available from
May 30, 2014